Search Results - "HALTON, D. E"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression by ELDER, D. J. E, HALTON, D. E, HAGUE, A, PARASKEVA, C

    Published in Clinical cancer research (01-10-1997)
    “…Cyclooxygenase (COX) catalyzes the conversion of arachidonic acid to prostaglandin H2. The inducible isoform, COX-2, promotes colorectal tumorigenesis, and…”
    Get full text
    Journal Article
  2. 2

    Apoptosis induction and cyclooxygenase‐2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase‐2‐selective non‐steroidal anti‐inflammatory drug NS‐398 by Elder, Douglas J.E., Halton, Dawn E., Crew, Tracey E., Paraskeva, Christos

    Published in International journal of cancer (15-05-2000)
    “…We determined the effect of the highly selective cyclooxygenase‐2 (COX‐2) inhibitor NS‐398 on proliferation, apoptosis and COX‐2 regulation in 3 pre‐malignant…”
    Get full text
    Journal Article
  3. 3

    The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells by Elder, Douglas J.E., Halton, Dawn E., Playle, Laura C., Paraskeva, Christos

    Published in International journal of cancer (20-05-2002)
    “…Nonsteroidal antiinflammatory drugs (NSAIDs) can prevent colorectal tumorigenesis in humans and in rodents. In vitro and in vivo studies indicate that one of…”
    Get full text
    Journal Article